Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Moodys
QuintilesIMS
Merck
Johnson and Johnson
McKesson
US Army
Cerilliant

Generated: June 19, 2018

DrugPatentWatch Database Preview

PILOPINE HS Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Pilopine Hs, and what generic alternatives are available?

Pilopine Hs is a drug marketed by Alcon and is included in one NDA.

The generic ingredient in PILOPINE HS is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
Summary for PILOPINE HS
Drug patent expirations by year for PILOPINE HS
Synonyms for PILOPINE HS
(+)-Pilocarpine hydrochloride
(3S-cis)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone hydrochloride
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one hydrochloride
(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]oxolan-2-one hydrochloride
(3S,4R)-3-ethyl-4-[(1-methylimidazol-5-yl)methyl]-3,4,5-trihydrofuran-2-one, c hloride
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one hydrochloride
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one;hydrochloride
(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one hydrochloride
(3S,4R)-3-Ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone Hydrochloride
(3S,4R)-4,5-Dihydro-3-ethyl-4-(1-methyl-1H-imidazol-5-ylmethyl)-2(3H)-furanone hydrochloride
0WW6D218XJ
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, hydrochloride (1:1), (3S,4R)-
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, monohydrochloride, (3S-cis)-
2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, monohydrochloride, (3S,4R)-
2(3H)-Furanone, monohydrochloride, (3S-cis)-
3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydro-2(3H)-furanone hydrochloride
54-71-7
5881AF
AC1L1LEC
AC1Q3EQS
Adsorbocarpine
AI3-61859
Akarpine
AKOS005267231
Almocarpine
Ami-pilo
Amistura P
AN-41661
ARONIS24309
BBC/465
BC245589
CCG-100757
CHEMBL1200330
component of Epicar
component of Pilocar
CPD000059053
CS-2973
D02200
DTXSID2041096
EINECS 200-212-5
EU-0100950
FT-0631237
HY-B0726
Isopto carpine
Isopto carpine (TN)
Isopto-carpine
KB-62493
KS-0000478G
LP00950
LS-109779
MFCD00012722
MI-Pilo Ophth Sol
Mistura P
MLS000069454
MLS000758210
MLS001076314
MLS001424017
MolPort-003-939-125
NC00007
NCGC00094254-01
NCGC00261635-01
NSC 5746
NSC-5746
NSC5746
Opera_ID_1616
P 6503
PILO
Pilocar
Pilocar SMP
Pilocarpal
Pilocarpin Hcl
Pilocarpine (Hydrochloride)
Pilocarpine HCl
Pilocarpine hydrochloride
Pilocarpine hydrochloride (JP17/USP)
Pilocarpine hydrochloride [USAN:JAN]
Pilocarpine hydrochloride [USP:JAN]
Pilocarpine hydrochloride, >=98% (titration), powder
Pilocarpine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Pilocarpine hydrochloride, meets USP testing specifications
Pilocarpine Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur
Pilocarpine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Pilocarpine hydrochlororide
Pilocarpine monohydrochloride
Pilocarpine muriate
pilocarpine-hcl
Pilocarpine, hydrochloride
PILOCARPINE, MONOHYDROCHLORIDE
Pilocel
Pilokarpin monohydrochloride
Pilomiotin
Pilopine
Pilopine HS (TN)
Pilopine HS Gel
Pilovisc
regid855931
RNAICSBVACLLGM-GNAZCLTHSA-N
s4231
Salagen
SAM001246962
Sanpilo (TN)
SBB006456
SC-47863
SC-50867
SCHEMBL41427
SMR000059053
Sno pilo
Spersacarpine hydrochloride
SR-01000075339
SR-01000075339-1
ST057163
Tox21_500950
UNII-0WW6D218XJ
WLN: T5OVTJ C2 D1- DT5N CNJ C1 &GH

US Patents and Regulatory Information for PILOPINE HS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon PILOPINE HS pilocarpine hydrochloride GEL;OPHTHALMIC 018796-001 Oct 1, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Express Scripts
Queensland Health
Covington
Mallinckrodt
Harvard Business School
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.